A6816412
Prostaglandin E1 , ≥98%(HPLC) , 745-65-3
Synonym(s):
Alprostadil;Prostaglandin E1;PGE?;PGE1;Prostaglandin E1
CAS NO.：745-65-3
Empirical Formula: C20H34O5
Molecular Weight: 354.49
MDL number: MFCD00077860
EINECS: 212-017-2
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB159.20 | In Stock |
|
| 25MG | RMB532.00 | In Stock |
|
| 100MG | RMB1326.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 115-116 °C |
| alpha | -64 º (c=1.0, C2H5OH) |
| Boiling point: | 407.69°C (rough estimate) |
| Density | 1.0458 (rough estimate) |
| refractive index | 1.6120 (estimate) |
| storage temp. | -20°C |
| solubility | ethanol: 1 mg/mL |
| form | powder |
| pka | pKa 4.85± 0.07(H2O,t=25±0.1,I=0.1(NaCl)) (Uncertain) |
| color | White to off-white |
| Water Solubility | insoluble |
| Merck | 13,7968 |
| BRN | 5294062 |
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month. |
| InChIKey | GMVPRGQOIOIIMI-DWKJAMRDSA-N |
Description and Uses
Prostaglandin E1 is an endogenous prostaglandin with vasodilatory, anti-platelet, and anti-hypertensive activities. It is in clinical use for the treatment of erectile dysfunction and the emergency management of infants with patent ductus arteriosus. It has also been used in the treatment of peripheral arterial occlusive disease (PAD).
For use in cell culture applications for the study of prostaglandin regulated cell signaling and gene regulation.
Safety
| Symbol(GHS) |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301+P310+P330 |
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-36/37/38-61 |
| Safety Statements | 36-26 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | GY4569800 |
| F | 8-10 |
| HazardClass | 6.1(b) |
| PackingGroup | III |
| HS Code | 29375000 |
